The partners’ study combines Neon’s personal neoantigen vaccine and Signatera’s circulating tumor DNA assay in a trial for metastatic non-small cell lung cancer.
Read More
Vectra provides important information to help rheumatologists identify patients at increased risk of joint damage.
Read More
Genomics England names Congenica as its clinical decision support service partner for the delivery of the NHS genomic medicine service.
Read More
The Lantern Project will expand access to free diagnostic genetic testing for a number of lysosomal storage disorders, for which tens of thousands go undiagnosed.
Read More
Healthcare professionals can use the BRACAnalysis CDx assay to identify patients with HER2-negative metastatic breast cancer who have a germline BRCA mutation and are eligible for treatment with Pfizer’s Talzenna.
Read More